Cardiology and Vascular Health: Pathophysiology, Therapeutics and Epidemiology

Dear Colleagues,

Cardiovascular diseases (CVDs) are among the most critical public health challenges in the modern world. Atherosclerosis is the main pathogenetic process leading to the development of CVDs. In the course of atherosclerosis, coronary heart disease, cerebrovascular disease, and peripheral arterial disease may develop. Diabetes, hypertension, dyslipidemia, obesity, smoking, and low physical activity are among the most important modifiable cardiovascular risk factors. Improving our knowledge regarding CVDs is essential in order to achieve superior patient care. Research in this area should, on the one hand, concern the diagnosis and treatment of overt cardiovascular disease, and on the other hand, focus on the identification of the dysfunction of the cardiovascular system at the subclinical level, which may affect therapeutic management and prevent the development of cardiovascular events. An individual approach to each patient is essential, which is in accordance with the concept of personalized medicine. Genetic testing also plays a key role in this regard. I cordially invite scientists from around the world to share the results of their research addressing the epidemiology, pathogenesis, and treatment of CVDs in this Special Issue.

Dr. Grzegorz K. Jakubiak
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.